These data suggest that PRAP1-mediated elevation of MAD1 may compete with BUBR1 to bind to MAD2, subsequently destroying the formation of MCC, resulting in escape from the supervision of MCC in HCT-116/DDP cells. This evidence concerns the gene PRAP1 and Merkel cell skin cancer.